Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond (vol 10, pg 127, 2011)

被引：3
|
作者：
Quintas-Cardama, Alfonso
Kantarjian, Hagop
Cortes, Jorge
Verstovsek, Srdan
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2011年 / 10卷 / 04期
关键词：
D O I：
10.1038/nrd3432
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Nature Reviews Drug Discovery 10, 127–140 (2011) The information presented in Table 2 on the compound SB1518 was incorrect; the correct information is provided below, and has been corrected online.
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Cortes, Jorge
    Verstovsek, Srdan
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (02) : 127 - 140
  • [2] Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
    Alfonso Quintás-Cardama
    Hagop Kantarjian
    Jorge Cortes
    Srdan Verstovsek
    Nature Reviews Drug Discovery, 2011, 10 : 127 - 140
  • [3] Erratum: Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
    Alfonso Quintás-Cardama
    Hagop Kantarjian
    Jorge Cortes
    Srdan Verstovsek
    Nature Reviews Drug Discovery, 2011, 10 : 318 - 318
  • [4] Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
    Rosenthal, Allison
    Mesa, Ruben A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1265 - 1276
  • [5] The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
    Hobbs, Gabriela S.
    Rozelle, Sarah
    Mullally, Ann
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 613 - +
  • [6] Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature
    Hunter, Anthony M.
    Bose, Prithviraj
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1391 - 1404
  • [7] Janus kinase 2 inhibitors in myeloproliferative disorders
    Lucia, Eugenio
    Recchia, Anna Grazia
    Gentile, Massimo
    Bossio, Sabrina
    Vigna, Ernesto
    Mazzone, Carla
    Madeo, Antonio
    Morabito, Lucio
    Gigliotti, Vincenzo
    De Stefano, Laura
    Caruso, Nadia
    Servillo, Pasquale
    Franzese, Stefania
    Bisconte, Maria Grazia
    Gentile, Carlo
    Morabito, Fortunato
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (01) : 41 - 59
  • [8] Treatment of Myeloproliferative Neoplasms with Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety
    Long, Edouard
    Dunn, Roberta
    Li Gagnon, Laura
    Harrison, Claire
    Yang, Yunfan
    O'Sullivan, Jennifer
    BLOOD, 2024, 144 : 3168 - 3169
  • [9] Janus Kinase 2 (JAK2) Inhibitors for the Treatment of Myeloproliferative Neoplasm (MPN)
    Purandare, Ashok V.
    Lorenzi, Matthew V.
    Lombardo, Louis J.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 211 - 227
  • [10] Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta-Analysis of Cardiovascular Safety
    Dunn, Roberta
    Long, Edouard
    Gagnon, Laura Li
    Harrison, Claire
    Yang, Yunfan
    O'Sullivan, Jennifer
    EJHAEM, 2025, 6 (01):
12345